Savara Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

Savara Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Savara Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
Savara Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Published Sep 22, 2016
29 pages — Published Sep 22, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Savara Inc. (Savara) is a specialty pharmaceutical company which focuses on the development of drugs for the treatment of serious and rare respiratory diseases. Its lead product candidate, AeroVanc, is a dry powder form of vancomycin hydrochloride. The companys AeroVanc is developed for the treatment of Methicillin Resistant Staphylococcus Aureus (MRSA) related bronchopneumonia lung infection in cystic fibrosis patients. Savara is conducting clinical studies on two products that include Molgradex and Alveodex.

Savara Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharmaceuticals & Healthcare eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial me

  
Source:
Document ID
GDPH185401D
Country
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents23
  List of Tables31
  List of Figures41
Savara Inc., Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 201642
Savara Inc., Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 201661
Savara Inc., Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 201671
Savara Inc., Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 201681
Savara Inc., Medical Devices Deals, 2010 to YTD 201691
Savara Inc., Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 2016101
Savara Inc., Pharmaceuticals &Healthcare, Deal Details1115
  Venture Financing111
    Savara Pharma Raises USD20 Million in Series C Financing Round111
    Savara Pharma Raises Additional USD5.5 Million in Financing Round121
    Savara Pharma Raises USD4.5 Million in Financing Round131
    Savara Pharma Raises US$14 Million In Series B Financing142
    Savara Pharma Raises Additional USD0.04 Million in Financing Round161
    Savara Pharma Raises Additional USD0.06 Million in Financing Round171
  Partnerships181
    Serendex Pharma Enters into Agreement with CMC Biologics For Factor VII181
  Licensing Agreements191
    NobelPharma Enters into Licensing Agreement with Savara191
    NobelPharma Enters into Licensing Agreement with Serendex Pharma201
  Equity Offering211
    Serendex Pharma Raises USD12.7 Million Rights Offering of Shares212
    Serendex Pharma Completes IPO for USD11 Million232
  Acquisition251
    Savara Pharma Acquires Serendex Pharma251
Savara Inc. - Key Competitors261
Key Employees271
Locations And Subsidiaries281
  Head Office281
  Other Locations &Subsidiaries281
Appendix291
  Methodology291
  About GlobalData291
  Contact Us291
  Disclaimer291

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "Savara Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile" Sep 22, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Savara-Inc-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-25414>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). Savara Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sep 22, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Savara-Inc-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-25414>
  
US$ 250.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research